Estrogen receptor β-Selective Phytoestrogenic (Phyto-β-SERM) Formulation Prevents Physical and Neurological Changes in a Preclinical Model of Human Menopause

類似資料

• Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in peri- and postmenopausal women
  著者:: Hernandez, Gerson, 等
  出版事項: (2018)
• Safety and feasibility of estrogen receptor β targeted PhytoSERM formulation for menopausal symptoms: Phase 1b/2a randomized clinical trial
  著者:: Schneider, Lon S., 等
  出版事項: (2019)
• Potentiation of Brain Mitochondrial Function by S-equol and R/S-equol Estrogen Receptor β Selective PhytoSERM Treatments
  著者:: Yao, Jia, 等
  出版事項: (2013)
• Early Intervention with an Estrogen Receptor β-Selective Phytoestrogenic Formulation Prolongs Survival, Improves Spatial Recognition Memory, and Slows Progression of Amyloid Pathology in a Female Mouse Model of Alzheimer’s Disease
  著者:: Zhao, Liqin, 等
  出版事項: (2013)
• Retrospective Analysis of PhytoSERM for Management of Menopause-Associated Vasomotor Symptoms and Cognitive Decline: A Pilot Study on Pharmacogenomic Effects of Mitochondrial Haplogroup and APOE Genotype on Therapeutic Efficacy
  著者:: Wang, Yiwei, 等
  出版事項: (2020)